Live
- Fatal Fire Erupts In Hotel Near Patna Junction, Claims Six Lives
- Congress Challenges PM Modi's Allegations: Calls Out "Falsehoods" Amidst Electoral Rhetoric
- CPI(M) leader seeks Calcutta HC’s attention over Bengal CM's anti-judiciary comments
- Aparna Yadav Challenges Akhilesh Yadav's Candidacy In Kannauj: No Longer A Smooth Ride For Samajwadi Party
- A constable who helped an old woman in a very dangerous place
- WBSSC Claims Eligibility For 19,000 Dismissed Staff Amidst Teacher Recruitment Scandal
- Tollywood’s shifting landscape: The growing influence of OTT platforms
- YSR Congress Party MLA candidate KK Raju campaigns in 23rd Ward Priyadarshini Colony
- Leaders and Residents Welcome TDP Candidates Pulivarthi Nani and Daggumalla Prasada Rao in Tirupati
- 30 Families Switch Allegiance from YSR Congress to Telugu Desam Party in Batladinne Village
Remdesivir effective against virus: Study
Highlights
Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published, three weeks after America's top infectious diseases expert said the study showed the medication has "clear-cut" benefits
London: Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published, three weeks after America's top infectious diseases expert said the study showed the medication has "clear-cut" benefits.
Complete results from the research, which was carried out by US government agency the National Institute of Allergy and Infectious Diseases, were published by leading medical periodical the New England Journal of Medicine.
The United States authorised the emergency use of remdesivir in hospitals on May 1, followed by Japan, while Europe is considering following suit.
Next Story
ADVERTISEMENT
